Dr. Robyn Lynette grew up in a cult, spent 14 years in corporate, played competitive beach volleyball, and started college at 32. She now works as a high-performance business psychologist and “professional confidant” for founders, funders, and executives who want an edge, not a pep talk.

She joins Katie Whitcraft and Maria Pienaar to dig into the things that sink founders quietly: hyper-independence that kills delegation, imposter syndrome, busy-ness that gets mistaken for productivity, and the toxic team member everyone can see and no one will address.

Along the way Robyn explains how to tell resilience apart from stubbornness, why luck is mostly preparation meeting opportunity, and how a company's culture gets set on purpose or by default. Maria shares what it was like to be one of the first female engineers in her field, and how she took on a boardroom “hyena pack” one honest conversation at a time. Robyn ends with the single piece of psychological armor she'd give every founder: if there's no water in the well, stop going there looking for a drink.

Find Robyn on LinkedIn as Dr. Robyn Lynette, at mentalmacgyver.com, and through her memoir “I'd Like To Thank The Cartel For Getting Me Out Of The Cult” at thankthecartel.com.

Ops or Die is hosted by Katie Whitcraft and Maria Pienaar of ScaleSpark. For more on how we help founders run smarter operations, visit scalespark.ai.

Most founders treat patents as paperwork for later. That delay can cost them the asset itself.

In this episode of Ops or Die, Maria Pienaar and Katie Whitcraft sit down with Shem Lachhman, managing partner and co-founder of Menlo Park Patents, to unpack why intellectual property belongs in your operations plan from the start. Shem paid for his own patents as a frustrated tech founder, then built a fixed-fee firm now filing roughly 1,000 applications a year at a 95% approval rate.

What you will learn

• Why the US first-to-file system means you file now and file fast, before a prototype even exists
• The 12-month grace period, and why founders should stay quiet and file before they publish
• The most common mistake, assuming your idea is not patentable, when only an examiner and the courts get to decide that
• How patents raise valuation, attract investors, and act as an insurance policy if the company fails
• How to position your patent portfolio in a pitch deck, including a future-filings roadmap

Connect with Shem at MenloParkPatents.com or on LinkedIn, and mention the code ScaleSpark for 10% off.

Ops or Die is hosted by Maria Pienaar and Katie Whitcraft of ScaleSpark. Make your operations smart at ScaleSpark.ai.

She got FDA clearance for a transparent surgical mask in March 2020. Two months later, ClearMask was shipping worldwide — and her four co-founders still had day jobs.

Elyse Heob is the founder behind two healthcare exits: a corporate wellness company acquired in 2016, and ClearMask, which she grew from zero to $45M without ever taking outside investment (19 million masks worldwide). Now she coaches early-stage founders on the parts of the job nobody puts on the highlight reel.

In this Ops or Die conversation with Katie Whitcraft and Maria Pienaar, Elyse breaks down how founders keep underpricing time when they buy tools, why a regulated-industry mindset is what separates founders who cross $1M to $10M from ones who stall, and how "Swiss Army knife" hires kept ClearMask agile at a fraction of its peer headcount. She and the hosts also dig into founder blindness (why you cannot see your own product), business continuity during fundraising, and why titles should bend to fit the people you have.

If you have been telling yourself you'll fix ops later, this is the episode that will change your mind.

Key topics: startup operations, healthcare startups, FDA regulatory strategy, non-dilutive fundraising, accelerators, hiring for aptitude, business continuity, founder resilience, fractional COO, SmartOps

Guest: Elyse Heob — Founder, ClearMask

Hosts: Katie Whitcraft and Maria Pienaar

Want smarter ops? Visit scalespark.ai